--------------------------------------------------------------- Program Number: 97989 --------------------------------------------------------------- ***Deadlines: 6/4/2012 Sponsor: Environmental Protection Agency Title: National Clean Diesel Funding Assistance Program Contact: Julie Henning Tel: 734-214-4442 Email: henning.julie@epa.gov Website:          http://www.grants.gov/search/search.do;jsessionid=G4tjPYmD3yhYnybqT2Th4yznvp5FLw5CL12QWn9nqkm1jYhNv0NC!482729280?oppId=166433&mode=VIEW Full Program:          http://www.epa.gov/air/grants_funding.html SYNOPSIS: Under this program, the sponsor is soliciting proposals nationwide for projects that achieve significant reductions in diesel emissions in terms of tons of pollution produced and diesel emissions exposure, particularly from fleets operating in areas designated by the Administrator as poor air quality areas. --------------------------------------------------------------- Program Number: 61287 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Directorate for Geosciences/NSF Title: Geophysics Contact: Robin Reichlin, Program Director Tel: 703-292-8556 Email: rreichli@nsf.gov Website:          http://www07.grants.gov/search/search.do?oppId=70033&mode=VIEW Full Program:          http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=13682 Deadline Note: Full proposal windows are as follows: May 5, 2012 - June 5, 2012; and November 5, 2012 - December 5, 2012. SYNOPSIS: This program supports basic research in the physics of the solid earth to explore its composition, structure, and processes. --------------------------------------------------------------- Program Number: 03691 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Identifying Non-coding RNA Targets for Cancer Early Detection and Prevention (R01) Contact: Wendy Wang, Ph.D., M.Sc. Tel: 301-594-7607 Email: wangw@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-199.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications from institutions/organizations on the discovery and characterization of non-coding (nc) RNAs in preneoplasias and early stage cancers to: 1) improve early cancer detection, intervention, and prevention; 2) predict risk of progression from preneoplasia to cancer, and 3) distinguish benign lesions from precancerous lesions. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 72509 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials (R01) Contact: Magdalena Thurin, Ph.D. Tel: 301-496-1591 Email: thurinm@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-013.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI) encourages the submission of Research Project Grant (R01) applications from institutions and organizations to validate the clinical utility of new molecular diagnostics for determining prognosis or predicting response to therapy or toxicity for cancer. The Cancer Diagnosis Program (CDP) and the Cancer Therapy Evaluation Program (CTEP) at the NCI are cooperatively sponsoring this FOA with the purpose to transition of candidate biomarkers from initial correlative observations into diagnostics that are suitable for use in clinical trials to assess the clinical validity of a marker. This program will support research projects to improve clinical decision-making in the care of cancer patients and as such will support studies that use tumor specimens linked to specific treatment and clinical outcome information. This FOA is not appropriate for molecular diagnostics discovery projects. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 07587 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R01) Contact: Abby G. Ershow, Sc. D., FAHA Tel: 301-435-0550 Email: ershowa@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-211.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites hypothesis-testing research applications that capitalize on the unique capabilities of Virtual Reality (VR) technologies to visualize outcomes, teach, motivate, and to extend the health care and learning environments, in order to foster to foster desirable eating, physical activity, self-care, and other health-related behaviors necessary for prevention and management of obesity and diabetes. Of highest interest are well-designed multidisciplinary projects drawing on expertise in VR technologies and biomedical behavioral and pedagogical sciences. The overall goal is to develop the potential of VR technologies as research tools for behavioral science-oriented studies in diabetes and obesity, and as practical tools for clinical and public health-level prevention and management of obesity and diabetes. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20022 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Getting from Genes to Function in Lung Disease (R01) Contact: Susan Banks-Schlegel, Ph.D. Tel: 301-435-0202 Email: schleges@nhlbi.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-110.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadline for receipt of standard R01 applications under this announcement is June 5, 2012, by 5:00 PM local time of applicant organization. The deadline for receipt of AIDS-related applications is September 7, 2012, by 5:00 PM local time of applicant organization. This program will expire on September 8, 2012. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) invites applications that propose to characterize the function of gene(s) and their associated variants identified by genome-wide association studies (GWAS) or other genetic approaches to be involved in lung diseases. Studies should use integrated approaches across scientific disciplines to determine the pathobiological function of these genes. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 58262 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: Ethical Legal and Social Implications (ELSI) of Genomic Research Regular Research Program (R01) Contact: Dr. Jean E. McEwen Tel: 301-402-4997 Email: jean.mcewen@nih.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-250.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors provide support for applications from institutions/organizations that propose to study the ethical, legal and social implications (ELSI) of human genome research. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 11079 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research Opportunities in Obstetric Fistula (R01) Contact: Susan F. Meikle, M.D., M.S.P.H. Tel: 301- 273-8541 Email: meikles@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-141.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications that propose to investigate epidemiologic, clinical, social, and behavioral interventions to improve the identification, prevention, treatment, and social circumstances of women at risk for or with obstetric fistula. The purpose of this FOA is not to address service delivery issues that have been outlined in the obstetric fistula program development materials distributed by WHO although it is recognized that improving financial access to care, transportation of women in labor, and obstetric service coverage is critical for reducing and eliminating the obstetric fistula rate. Rather, this FOA requests research applications that complement the programmatic efforts to deliver better and more timely health care during labor, delivery, and post partum. Obstetric fistula is a critical maternal and child health issue in developing countries. Multiple approaches including both improving emergency obstetric care and improved clinical, social and behavioral care are needed to reduce its toll on women and children. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 82115 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Mechanisms of Adverse Drug Reactions in Children (R01) Contact: George P. Giacoia, MD Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-051.html Deadline Note: The sponsor requests that optional letters of intent be submitted thirty days prior to the application due date. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications for projects that enhance the state-of-the-science on the molecular and cellular, genetic and epigenetic mechanisms involved in the production of adverse drug reactions in children. The objective of this announcement includes research on the role of ontogeny and the characterization of pharmacogenetic and developmental variations of drug metabolizing enzymes (DMEs), transporters, ion channels, receptors and signaling pathways that are responsible for drug toxicity in the pediatric population. This FOA will use the NIH Research Project Grant (R01) award mechanism. --------------------------------------------------------------- Program Number: 02699 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Innovations in Biomedical Computational Science and Technology (R01) Contact: Peter Lyster, Ph.D. Tel: 301-451-6446 Email: lysterp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-218.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors offer support for research and developments in computational science and technology that will support rapid progress in areas of scientific opportunity in biomedical research. As defined here, biomedical computing or biomedical information science and technology includes database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic collaboration, as well as computational and mathematical research including the development of structural, functional, integrative, and analytical models and simulations. This program will use the NIH R01 award mechanism. --------------------------------------------------------------- Program Number: 85825 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Collaborative Research for Molecular and Genomic Studies of Basic Behavior in Animal Models (R01) Contact: Laurie Tompkins, Ph.D. Tel: 301-594-0943 Email: tompkinL@nigms.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-125.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors offer support for collaborative research, involving behavioral scientists and investigators with expertise in molecular biology and/or genomics, which addresses questions about basic mechanisms of behavior in animal models. This PA will use the R01 award mechanism. --------------------------------------------------------------- Program Number: 91465 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: Neurobiology of Migraine (R01) Contact: Linda L. Porter, Ph.D. Tel: 301-496-9964 Email: porter@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-258.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations that intend to perform innovative research that will expand our current knowledge of neurobiological mechanisms underlying migraine headache, examine the role of neuromodulators, genetic and environmental influences in migraine susceptibility, and explore new targets for therapy development. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 02502 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R01) Contact: Wen G. Chen, Ph.D. Tel: 301496-9350 Email: chenw@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-193.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 6, 2012. SYNOPSIS: The sponsors invite applications from institutions/organizations that propose to (1) study biological, neurobiological, psychosocial, and clinical mechanisms and processes by which aging and/or age-related diseases affect the experience of pain, (2) examine biological, neurobiological, psychosocial, and clinical factors that impact pain experience and prevalence in older people, (3) evaluate existing pain assessment and/or management approaches in older adults, or (4) develop new assessment methods and/or management strategies for pain with particular attention to the needs of older adults. Studies involving animal models or human subjects are appropriate under this program announcement. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05092 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Secondary Analyses of Existing Data Sets and Stored Biospecimens to Address Clinical Aging Research Questions (R01) Contact: Chhanda Dutta, Ph.D. Tel: 301-435-3048 Email: duttac@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-265.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications to support short term projects involving secondary analysis of existing data sets or stored biospecimens, to address clinically-related issues on aging changes influencing health across the life span, and/or on diseases and disabilities in older persons. This funding opportunity announcement (FOA) will support activities addressing specific hypotheses in clinical aging research and/or to inform the design and implementation of future epidemiologic or human intervention studies, or current geriatric practice in maintenance of health, management of disease, and prevention of disability. Existing data sets may also be used to develop and test new statistical analytical approaches. Costs for archiving of data to be made publicly available may be included in the budget, as long as the archival activities are related to the proposed secondary analyses. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 46815 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Alzheimer's Disease Pilot Clinical Trials (R01) Contact: Laurie M. Ryan, Ph.D. Tel: 301-496-9350 Email: ryanl@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-100.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 18, 2011; and then the standard deadlines of June 5, October 5 and February 5 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite qualified investigators to submit research grant applications for pilot clinical trials using pharmacologic and/or behavioral interventions directed toward the prevention and treatment of the cognitive and behavioral symptoms of mild cognitive impairment (MCI), Alzheimer's disease (AD), and age-related cognitive decline. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16837 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Strategies for Treatment of Young Adults with Alcohol Use Disorders (R01) Contact: Margaret E. Mattson, Ph.D. Tel: 301-443-0638 Email: mmattson@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-246.html Deadline Note: The sponsor encourages optional letters of intent, to be submitted not more than thirty days before the application receipt date. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications to support new research on the treatment of young adults (18-25 years of age) with alcohol use disorders. Compared to all other age groups, the prevalence of periodic heavy or high-risk drinking is greatest among young adults aged 18 to 25. Alcohol use disorders, including alcohol dependence, also peak during this critical period during which profound developmental changes occur. Despite having the highest prevalence of drinking, interventions for this group have been understudied. Gaps exist in understanding how to effectively engage this group in treatment, which treatments are the most effective, and how to maintain treatment gains in the longer term after treatment. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16840 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Strategies for Treatment of Young Adults with Alcohol Use Disorders (R03) Contact: Margaret E. Mattson, Ph.D. Tel: 301-443-0638 Email: mmattson@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-247.html Deadline Note: The sponsor encourages optional letters of intent, to be submitted not more than thirty days before the application receipt date. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16 and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications to support new research on the treatment of young adults (18-25 years of age) with alcohol use disorders. Compared to all other age groups, the prevalence of periodic heavy or high-risk drinking is greatest among young adults aged 18 to 25. Alcohol use disorders, including alcohol dependence, also peak during this critical period during which profound developmental changes occur. Despite having the highest prevalence of drinking, interventions for this group have been understudied. Gaps exist in understanding how to effectively engage this group in treatment, which treatments are the most effective, and how to maintain treatment gains in the longer term after treatment. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 16841 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Strategies for Treatment of Young Adults with Alcohol Use Disorders (R21) Contact: Margaret E. Mattson, Ph.D. Tel: 301-443-0638 Email: mmattson@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-248.html Deadline Note: The sponsor encourages optional letters of intent, to be submitted not more than thirty days before the application receipt date. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16 and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications to support new research on the treatment of young adults (18-25 years of age) with alcohol use disorders. Compared to all other age groups, the prevalence of periodic heavy or high-risk drinking is greatest among young adults aged 18 to 25. Alcohol use disorders, including alcohol dependence, also peak during this critical period during which profound developmental changes occur. Despite having the highest prevalence of drinking, interventions for this group have been understudied. Gaps exist in understanding how to effectively engage this group in treatment, which treatments are the most effective, and how to maintain treatment gains in the longer term after treatment. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 16989 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Behavioral Regulation Mechanisms of Alcohol Dependence and Related Phenotypes (R01) Contact: Ivana Grakalic, Ph.D. Tel: 301-443-7600 Email: igrakalic@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-255.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications that propose to examine the mechanisms of behavioral regulation contributing to the behavioral characteristics of alcohol dependence. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20844 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Neuroimmune Mechanisms Of Alcohol Related Disorders (R01) Contact: Changhai Cui, PhD Tel: 301-443-1678 Email: changhai.cui@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-064.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose study the neuroimmune mechanisms of alcohol related disorders. Studies supported by this FOA will provide fundamental insights of neuroimmune mechanisms underlying brain functional and behavioral changes induced by alcohol. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24138 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Drug Abuse Prevention Intervention Research (R01) Contact: Kevin P. Conway, Ph.D., Acting Branch Chief Tel: 301-443-6504 Email: kconway@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-311.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose to advance the science of drug abuse and drug-related HIV prevention through 1) the development of novel prevention approaches, 2) the testing of novel and adapted prevention intervention approaches 3) the elucidation of processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions, and 4) the development of new methodologies suitable for the design and analysis of prevention research studies. Programs of research are intended to provide pathways toward the discovery of population-level approaches for the prevention of drug abuse and dependence, drug-related problems (such as mental health, interpersonal violence, criminal involvement, and productivity loss), and drug-related disorders (e.g., comorbid drug and psychiatric disorders; infections such as HIV, hepatitis B, and hepatitis C). This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 72593 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Behavioral & Integrative Treatment Development Program (R01) Contact: Lisa Onken, Ph.D. Tel: 301-443-2235 Email: Lisa_Onken@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-012.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invites applications for Stage II or Stage III research to conduct clinical trials, examine mechanisms of behavior change, determine dose-response, optimize combinations, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 75292 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01) Contact: Cora Lee Wetherington, Ph.D. Tel: 301-435-1319 Email: cwetheri@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-11-047.html Deadline Note: Applicants may be submitted through Grants.gov on or after January 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25809 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Office of Behavioral and Social Sciences Research/NIH/DHHS Title: Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care (R01) Contact: Wendy Nilsen, PhD Tel: 301-496-0979 Email: nilsenwj@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-024.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: This funding opportunity announcement (FOA) seeks Research Project Grant (R01) applications that propose to use a common conceptual model to develop behavioral interventions to modify health behaviors and improve health outcomes in patients with comorbid chronic diseases and health conditions. Specifically, this FOA will support research in primary care that uses a multi-disease care management approach to behavioral interventions with high potential impact to improve patient-level health outcomes for individuals with three or more chronic health conditions. The proposed approach must modify behaviors using a common approach rather than administering a distinct intervention for each targeted behavior and/or condition. Diseases and health conditions can include, but are not limited to: mental health disorders (e.g., depression), diabetes, smoking, obesity, chronic pain, alcohol and substance abuse and dependence, chronic obstructive pulmonary disorder, cancer and hypertension. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 19016 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (UM1) Contact: Deborah Winn, Ph.D. Tel: 301-594-9499 Email: winnde@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-167.html Deadline Note: The deadlines for receipt of optional letters of intent are:June 6, 2012, October 8, 2012, February 8, 2013, June 10, 2013, October 8, 2013. The deadlines for receipt of full applications are: July 6, 2012, November 8, 2012, March 8, 2013, July 10, 2013, November 8, 2013. This FOA will expire on November 9, 2013. SYNOPSIS: The sponsor invites applications to provide targeted infrastructure support for the core functions of Cancer Epidemiology Cohorts (CECs) and methodological research. This infrastructure can support existing or new CECs. This FOA will support core functions for CECs currently funded through other grant mechanisms by the Epidemiology and Genetics Program (EGRP) and other components of the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI). This FOA will utilize the UM1 Multi-Component Research Project Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 28403 --------------------------------------------------------------- ***Deadlines: 6/7/2012 Sponsor: National Energy Technology Laboratory/Department of Energy Title: Small Scale Coal-Biomass to Liquids (CBTL) Production and Feasibility Study of a Commercial Scale CBTL Facility Contact: Raelynn Honkus Tel: Email: Raelynn.Honkus@netl.doe.gov Website:          http://www.grants.gov/search/search.do;jsessionid=S2vXPpJDfpq9GdqyvKRKLDgy2bBv1qJs1dcwsHTtl6hTDQXzhtwJ!917914427?oppId=168173&mode=VIEW Full Program:          https://www.fedconnect.net/FedConnect/?doc=DE-FOA-0000703&agency=DOE SYNOPSIS: The sponsor seeks to award cooperative agreements for projects to (1) develop and test novel technologies for the economical and environmentally-sustainable conversion of coal-biomass feedstocks to liquid transportation fuels and (2) assess concepts and evaluate the feasibility of building and operating a commercial scale CBTL production facility. --------------------------------------------------------------- Program Number: 24943 --------------------------------------------------------------- ***Deadlines: 6/7/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Research Using Subjects From The Type 1 Diabetes TrialNet Natural History Study (Living Biobank) (DP3) Contact: Lisa M. Spain, Ph. D, Director Tel: 301-451-9871 Email: spainl@niddk.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-349.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after November 7, 2011. The deadlines for receipt of optional letters of intent are: November 7, 2011; and May 7, 2012 . The deadlines for receipt of full applications are: December 7, 2011; and June 7, 2012 by 5:00 PM local time of applicant organization. This FOA will expire on June 8, 2012. SYNOPSIS: The sponsor invites applications for ancillary studies that use subjects enrolled in (or screened for participation in) the Type 1 Diabetes TrialNet clinical trials network. Studies are expected to generate scientific discoveries on disease mechanisms, disease pathogenic processes, and biomarkers of disease progression or clinical responses. This FOA is not intended to fund clinical trials with endpoints for clinical efficacy (including but not limited to C-peptide preservation). This FOA will utilize the NIH DP3 Type 1 Diabetes Targeted Research Award. --------------------------------------------------------------- Program Number: 25007 --------------------------------------------------------------- ***Deadlines: 6/7/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3) Contact: Lisa M. Spain, Ph. D, Director Tel: 301-451-9871 Email: spainl@niddk.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-350.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after November 7, 2011. The deadlines for receipt of optional letters of intent are: November 7, 2011; and May 7, 2012 . The deadlines for receipt of full applications are: December 7, 2011; and June 7, 2012 by 5:00 PM local time of applicant organization. This FOA will expire on June 8, 2012. SYNOPSIS: The sponsor invites applications for ancillary studies using archived samples from selected type 1 diabetes clinical trials and studies. Ancillary studies are expected to generate scientific discoveries on disease mechanisms, disease pathogenic processes, and biomarkers of disease progression or clinical responses. This FOA will utilize the NIH DP3 Type 1 Diabetes Targeted Research Award. --------------------------------------------------------------- Program Number: 03947 --------------------------------------------------------------- ***Deadlines: 6/7/2012 Sponsor: Natural Resources Conservation Service/Department of Agriculture Title: Conservation Innovation Grants - New Hampshire Contact: Deborah Weymouth Tel: 603-868-9931 x 102 Email: deb.weymouth@nh.usda.gov Full Program:          http://www07.grants.gov/search/search.do;jsessionid=nKWPP0mKDPJpRyLD2lJ09W0CnbCFDxQyYdtQLNgQ4k12DK5ZrdFT!109354571?oppId=170999&mode=VIEW SYNOPSIS: The New Hampshire State Office of the USDA Natural Resources Conservation Service (NRCS) requests applications for Conservation Innovation Grants (CIG) to stimulate the development and adoption of innovative conservation approaches and technologies. Applications will be accepted from any eligible entity for projects within the State of New Hampshire. Funds will be awarded through a statewide competitive grants process. Applications are requested from eligible government or non-government organizations or individuals within the State of New Hampshire for competitive consideration of grant awards for projects between one and three years in duration. NRCS anticipates the availability of up to $134,000 of funds during fiscal year 2012 for the New Hampshire CIG program competition. --------------------------------------------------------------- Program Number: 03500 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: Environmental Protection Agency Title: Region 2 Wetland Program Development Grants Contact: Kathleen Drake, Grant Coordinator Tel: 212-637-3817 Email: Drake.kathleen@epa.gov Website:          http://www.grants.gov/search/search.do;jsessionid=QQPvPh7KpPptBhLvk32G2hs5hhRbmY1TyFMrTTlDPcVwnGKlnLR5!267572332?oppId=167173&mode=VIEW Full Program:          http://www.epa.gov/region2/water/wetlands/R2_FY12_WPDG_RFP.pdf SYNOPSIS: Wetland Program Development Grants (WPDGs) provide eligible applicants an opportunity to conduct and promote the coordination and acceleration of research, investigations, experiments, training, demonstrations, surveys, and studies relating to the causes, effects, extent, prevention, reduction, and elimination of water pollution. The goals of EPA’s wetland program include increasing the quantity and quality of wetlands in the U.S. by conserving and restoring wetland acreage and improving wetland condition. In pursuing these goals, EPA seeks to build the capacity of all levels of government to develop and refine effective, comprehensive programs for wetland protection and management. WPDGs provide States, Tribes, local governments, interstate agencies, and intertribal consortia an opportunity to carry out projects to develop and refine comprehensive wetland programs. --------------------------------------------------------------- Program Number: 14833 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: National Aeronautics & Space Administration Title: National Space Biomedical Research Institute Postdoctoral Fellowship Contact: Amanda Smith Hackler Tel: 713-798-7412 Email: postdoc@nsbri.org Website:          http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={0F3A5A9E-7921-979A-D273-43B749592F7A}&path=open Full Program:          http://nspires.nasaprs.com/external/viewrepositorydocument/cmdocumentid=309512/solicitationId=%7B0F3A5A9E-7921-979A-D273-43B749592F7A%7D/viewSolicitationDocument=1/NSBRI-RFA-12-02%20Post%20Doc.pdf SYNOPSIS: NSBRI is a NASA-funded, nonprofit research consortium charged with developing biomedical countermeasures and technologies for potential health problems that could occur in astronauts either during long-duration spaceflight, on exploration missions or on their return to Earth. NSBRI’s current program, aligned with NASA’s exploration objectives, consists of approximately 50 science and technology projects organized into research teams. NSBRI invites ground-based research applications. Proposals can address one of the seven existing NSBRI research teams, which has importance to both NSBRI and the NASA Human Research Program (HRP). --------------------------------------------------------------- Program Number: 28387 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: Golden Field Office/Department of Energy Title: Fuel Cell Powered Airport Ground Support Equipment Deployment Contact: Scott Schmitz Tel: 720-356-1774 Email: scott.schmitz@go.doe.gov Website:          http://www.grants.gov/search/search.do;jsessionid=QQPvPh7KpPptBhLvk32G2hs5hhRbmY1TyFMrTTlDPcVwnGKlnLR5!267572332?oppId=167233&mode=VIEW Full Program:          https://eere-exchange.energy.gov/#b354ca47-7a0c-44b0-b23e-7199c9074aef SYNOPSIS: DOE’s Fuel Cell Technologies Program seeks applications for projects to demonstrate and deploy fuel cell hybrid ground support equipment (GSE) vehicles at airport and/or air freight distribution center sites. Packaged solutions for polymer electrolyte membrane (PEM) fuel cell systems (5 to 20 kW) fueled by hydrogen with the ability to power a baggage tow tractor with 3,000 to 6,000 pounds (1,362 to 2,722 kg) towing capability for a minimum of 10 hours of continuous operation and 5000 total hours are sought. Applications must focus on developing, deploying, and validating systems in the field under real world operating conditions. The target market is commercial airports and air freight distribution centers used by passenger airlines and air freight industries. Approximately $2,500,000 in FY 2012 DOE funding is expected to be available for new awards under this announcement. DOE anticipates making 1-3 awards under this announcement depending on the size of the awards. --------------------------------------------------------------- Program Number: 05677 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: RFA-HL-12-024--Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R41/R42) Contact: Abby G. Ershow, Sc. D., FAHA Tel: 301-435-0550 Email: ershowa@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-HL-12-024.html Deadline Note: The deadlines for receipt of optional letters of intent are: June 13, 2011 (passed) and June 11, 2012. The deadlines for receipt of full applications are: July 11, 2011 and July 11, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: The sponsor invites applications that capitalize on the unique capabilities of Virtual Reality (VR) technologies to teach, motivate, visualize outcomes, and to extend the health care and learning environments for patients with obesity and diabetes. The VR technology proposed should foster desirable eating, physical activity, self-care, and other health-related behaviors necessary for prevention and management of obesity and diabetes. Of highest interest are well-designed multidisciplinary projects drawing on expertise in VR technologies and biomedical behavioral and pedagogical sciences. The overall goal is to develop the potential of Virtual Reality technologies as research tools for behavioral science-oriented studies in diabetes and obesity, and as practical tools for clinical and public health-level prevention and management of obesity and diabetes. This FOA will utilize the NIH R41/R42 Small Business Technology Transfer (STTR) Grants - Phase I, Phase II, and Fast-Track award mechanisms. --------------------------------------------------------------- Program Number: 97142 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: National Nuclear Security Administration Service Center/Department of Energy Title: National Laser Users' Facility Program (NLUF) Contact: William J. Parras Tel: 505-845-4021 Email: Bill.Parras@nnsa.doe.gov Website:          http://www.grants.gov/search/search.do;jsessionid=95ZHPthGGchjR8x2yb1wWmcJCSplpDVGXWvCL0Lh0mFCQyy5yTQJ!64499778?oppId=169973&mode=VIEW SYNOPSIS: The NLUF program is part of the Joint Program in High Energy Density Laboratory Plasmas, which is sponsored jointly by the U.S. Department of Energy (DOE)/National Nuclear Security Administration (NNSA), Office of Defense Science, and the Office of Fusion Energy, Office of Science. The NLUF provides access to the OMEGA Laser Facility for University and Industrial Scientists to conduct university and industry-led experiments in high-energy-density (HED) and Inertial Confinement Fusion (ICF). --------------------------------------------------------------- Program Number: 25547 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: Office of Science/Department of Energy Title: Community Sequencing Program - Quarterly Microbial Proposals Contact: Jim Bristow Tel: 925-296-5609 Website:          http://www.jgi.doe.gov/CSP/index.html Full Program:          http://www.jgi.doe.gov/CSP/user_guide/propschedule.html Deadline Note: Proposals for microbial isolates and resequencing proposals (<10 isolates) are accepted on a continuous basis and will be reviewed every quarter. Letters of intent are not required. Deadline for submission is 30 days prior to the review date. SYNOPSIS: The Community Sequencing Program (CSP) was created to provide the scientific community at large with access to high-throughput sequencing at the Department of Energy Joint Genome Institute (JGI) for projects of relevance to DOE missions. Sequencing projects will be chosen based on scientific merit--judged through independent peer review--and relevance to issues in global carbon cycling, alternative energy production, and biogeochemistry. --------------------------------------------------------------- Program Number: 28383 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: Department of the Air Force Title: RFP -- Environment & Energy Quality (E2Q) Technologies II Contact: Robin Bartley, Contracting Officer Tel: 937-255-0405 Email: robin.bartley@wpafb.af.mil Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=6edc4bea6aa0eb41e59e183bac100777&tab=core&_cview=0 A -- ENVIRONMENT & ENERGY QUALITY (E2Q) TECHNOLOGIES II - BROAD AGENCY ANNOUNCEMENT (BAA) - FULL SOLICITATION SOL BAA-12-10-PKM POC Robin Bartley, Pone: (937) 255-0405, Warren Assink, Phone: (937) 255-3480 WEB: FBO.gov Permalink https://www.fbo.gov/spg/USAF/AFMC/AFRLWRS/BAA-12-10-PKM/listing.html E-MAIL: robin.bartley@wpafb.af.mil, warren.assink@wpafb.af.mil robin.bartley@wpafb.af.mil, warren.assink@wpafb.af.mil NAICS: 541712 SOO Guidance DD Form 254 CDRLs DFARs Clause 252.209-7999 Task Order 2 Statement of Objectives Task Order 1 Statement of Objectives Statement of Work Initial Announcement The overall objective of this program is to execute environmental and energy (E2) RDT&E for the Air Force to meet goals, objectives, and metrics described in Executive Orders 13423 and 13514, and the Air Force Infrastructure Energy Plan 2010 and successor documents. AFRL/RXSC is seeking a system technology integrator to identify, test, evaluate, demonstrate, and transition alternative environmentally friendly and renewable energy technologies in one or more of the E2 technical areas as outlined in the BAA, page 2, 'Brief Program Summary'. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=6edc4bea6aa0eb41e59e183bac100777&tab=core&_cview=0 Posted 04/26/12 (W-SN02732833). (0117) --------------------------------------------------------------- Program Number: 28209 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: Golden Field Office/Department of Energy Title: Hydropower Advancement Project (HAP) - Standard Assessments to Increase Generation and Value Contact: Jane B. Sanders Tel: Email: HAPHydrofoa@go.doe.gov Website:          http://www.grants.gov/search/search.do;jsessionid=HvHbPNtZNSHKpwbCPXPmPcZPRFyVTb03FtGjqnqLQl2kR1Vsltcc!98924490?oppId=164353&mode=VIEW Full Program:          https://eere-exchange.energy.gov/#5a485f59-64c8-42b8-b2c0-dfa7eff7466e Deadline Note: Letter of intent are due May 3, 2012. Letters of Intent are optional. Letters of intent and accompanying abstracts will be used by DOE to organize and expedite the merit review process. They should not contain any proprietary or sensitive business information. Failure to submit such letters will not negatively affect a responsive application submitted in a timely fashion. Full applications must be received by June 14, 2012. SYNOPSIS: The Department of Energy (DOE), Office of Energy Efficiency & Renewable Energy (EERE), Wind and Water Power Program, is seeking applications from hydropower professionals to participate in the Hydropower Advancement Project (HAP) standard assessments activity. --------------------------------------------------------------- Program Number: 28519 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Idaho Operations Office/Department of Energy Title: Development of LWR Fuels with Enhanced Accident Tolerance Contact: Heather J. Merrill Tel: 208-526-1650 Email: merrilhj@id.doe.gov Website:          http://www.grants.gov/search/search.do;jsessionid=Q6JyPvjGGTKJMc6zRgWsj1ZNZxP12VfTT1sDwQyYQTLYJSVT6JjY!477727685?oppId=168693&mode=VIEW Full Program:          https://www.fedconnect.net/Fedconnect/PublicPages/PublicSearch/Public_Opportunities.aspx Deadline Note: Letters of Intent must be received by May 17, 2012. Applications must be received by June 15, 2012. SYNOPSIS: The U.S. Department of Energy (DOE) Office of Nuclear Energy, through this Funding Opportunity Announcement (FOA), seeks to facilitate the development and initial testing of light water reactor (LWR) fuel concepts with accident tolerant features. Program funding will be provided at a minimum of 20% industry cost-share, 80% Federal cost-share, to the awardee(s) for the purposes of completing early phase analysis and empirical data collection to assess the impacts of novel ATF. The total Government funding available for awards under this FOA is anticipated at $10M over two (2) years, subject to availability of funds. --------------------------------------------------------------- Program Number: 26893 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: U.S. Agency for International Development Title: Mexican Partnership Program Contact: Maritza Sarmiento, Acquisition Specialist Tel: 503-2501-3325 Email: mexicoaps@usaid.gov Full Program:          http://www07.grants.gov/search/search.do;jsessionid=7PKDPndG6m7fLcGXVNh1NKK7gVYhLC2cWTy9r3X1gWSRGVQ8xR1n!-992301837?oppId=141597&mode=VIEW Deadline Note: If the concept paper is judged to have sufficient merit, USAID will invite organizations to submit a full application. USAID/Mexico will inform unsuccessful applicants in writing, explaining briefly why the concept paper was not selected for the submission of a full application. Unsuccessful applicants may resubmit revised concept papers for consideration. SYNOPSIS: The United States Agency for International Development (USAID) Mission in Mexico is seeking concept papers and, later, applications from Mexican for‐profit and non‐for‐profit organizations to implement activities to support the Mexican Partnership Program related to global climate change, economic competitiveness, youth, human rights and rule of law. Eligible organizations include, but are not limited to, non‐government organizations (NGOs), associations, cooperatives, universities, civil society organizations, foundations, and private companies. USAID plans to hold regular information sessions on the APS in different locations in Mexico during February and March 2012. The information sessions will be organized by the five technical areas of the APS. USAID plans to hold information sessions as follows: Global Climate Change (Mexico city, Chiapas, Oaxaca); Competitiveness (Mexico City); Youth (Monterrey, Tijuana, Ciudad, Juarez); and Human Rights and Criminal Justice (Mexico City). Additional information sessions may be added depending on interest. Please contact Tere Garduño (tgarduno@usaid.gov) to be included on the invitation list for these sessions, and note which of the five technical areas is of interest. --------------------------------------------------------------- Program Number: 02628 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Identifying Non-coding RNA Targets for Cancer Early Detection and Prevention (R21) Contact: Wendy Wang, Ph.D., M.Sc. Tel: 301-594-7607 Email: wangw@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-200.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications from institutions/organizations on the discovery and characterization of non-coding (nc) RNAs in preneoplasias and early stage cancers to: 1) improve early cancer detection, intervention, and prevention; 2) predict risk of progression from preneoplasia to cancer, and 3) distinguish benign lesions from precancerous lesions. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 87502 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials (R21) Contact: Magdalena Thurin, Ph.D. Tel: 301-496-1591 Email: thurinm@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-014.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI) encourages the submission of Research Project Grant (R01) applications from institutions and organizations to validate the clinical utility of new molecular diagnostics for determining prognosis or predicting response to therapy or toxicity for cancer. The Cancer Diagnosis Program (CDP) and the Cancer Therapy Evaluation Program (CTEP) at the NCI are cooperatively sponsoring this FOA with the purpose to transition of candidate biomarkers from initial correlative observations into diagnostics that are suitable for use in clinical trials to assess the clinical validity of a marker. This program will support research projects to improve clinical decision-making in the care of cancer patients and as such will support studies that use tumor specimens linked to specific treatment and clinical outcome information. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 08320 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R21) Contact: Abby G. Ershow, Sc. D., FAHA Tel: 301-435-0550 Email: ershowa@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-212.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites exploratory/developmental research applications that capitalize on the unique capabilities of Virtual Reality (VR) technologies to visualize outcomes, teach, motivate, and to extend the health care and learning environments, in order to foster desirable eating, physical activity, self-care, and other health-related behaviors necessary for prevention and management of obesity and diabetes. Of highest interest are well-designed multidisciplinary projects drawing on expertise in VR technologies and biomedical behavioral, and pedagogical sciences. The overall goal is to develop the potential of VR technologies as research tools for behavioral science-oriented studies in diabetes and obesity, and as practical tools for clinical and public health-level prevention and management of obesity and diabetes. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23663 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: Ethical, Legal, and Social Implications (ELSI) of Genomic Research Exploratory/Developmental Research Grant Award (R21) Contact: Dr. Jean E. McEwen Tel: 301-402-4997 Email: jean.mcewen@nih.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-251.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. These applications should propose exploratory or novel studies that break new ground or extend previous discoveries toward new directions or applications. Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 58251 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: Ethical, Legal, and Social Implications (ELSI) of Genomic Research Small Research Grant Program (R03) Contact: Dr. Jean E. McEwen Tel: 301-402-4997 Email: jean.mcewen@nih.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-249.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications to study the ethical, legal and social implications (ELSI) of human genome research. These applications should be for small, self-contained research projects. Of particular interest are projects that propose focused legal, economic, philosophical or historical analyses of new or emerging issues. This FOA will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 88007 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute for Occupational Safety & Health/CDC/DHHS Title: NIOSH Small Research Grant Program (R03) Contact: Susan B. Board, M.S., Scientific Program Officer Tel: 404-498-2530 Email: sboard@cdc.gov Website:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-138.html Full Program:          http://www07.grants.gov/search/search.do?oppId=46753&mode=VIEW Deadline Note: This FOA will expire on September 8, 2012. SYNOPSIS: The sponsor provides support for projects designed to develop an understanding of the risks and conditions that are associated with occupational diseases and injuries, to explore methods for reducing risks and for preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. This FOA will utilize the NIH Small Research Grant (R03) award mechanism, --------------------------------------------------------------- Program Number: 20685 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research Opportunities in Obstetric Fistula (R03) Contact: Susan F. Meikle, M.D., M.S.P.H. Tel: 301- 273-8541 Email: meikles@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-142.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications that propose to investigate epidemiologic, clinical, social, and behavioral interventions to improve the identification, prevention, treatment, and social circumstances of women at risk for or with obstetric fistula. The purpose of this FOA is not to address service delivery issues that have been outlined in the obstetric fistula program development materials distributed by WHO although it is recognized that improving financial access to care, transportation of women in labor, and obstetric service coverage is critical for reducing and eliminating the obstetric fistula rate. Rather, this FOA requests research applications that complement the programmatic efforts to deliver better and more timely health care during labor, delivery, and post partum. Obstetric fistula is a critical maternal and child health issue in developing countries. Multiple approaches including both improving emergency obstetric care and improved clinical, social and behavioral care are needed to reduce its toll on women and children. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 20693 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research Opportunities in Obstetric Fistula (R21) Contact: Susan F. Meikle, M.D., M.S.P.H. Tel: 301- 273-8541 Email: meikles@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-143.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications that propose to investigate epidemiologic, clinical, social, and behavioral interventions to improve the identification, prevention, treatment, and social circumstances of women at risk for or with obstetric fistula. The purpose of this FOA is not to address service delivery issues that have been outlined in the obstetric fistula program development materials distributed by WHO although it is recognized that improving financial access to care, transportation of women in labor, and obstetric service coverage is critical for reducing and eliminating the obstetric fistula rate. Rather, this FOA requests research applications that complement the programmatic efforts to deliver better and more timely health care during labor, delivery, and post partum. Obstetric fistula is a critical maternal and child health issue in developing countries. Multiple approaches including both improving emergency obstetric care and improved clinical, social and behavioral care are needed to reduce its toll on women and children. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 98448 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Mechanisms of Adverse Drug Effects in Children (R03) Contact: George P. Giacoia, M.D. Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-052.html Deadline Note: The sponsor requests that optional letters of intent be submitted thirty days prior to the application due date. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications that propose to study the molecular, cellular and genetic mechanisms involved in the production of adverse drug reactions in children. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 01128 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: NIDCR Small Research Grants for Data Analysis and Statistical Methodology Applied to Genome-wide Data (R03) Contact: Emily L. Harris, Ph.D., M.P.H. Tel: 301-594-4846 Email: emily.harris@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-10-041.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications for research projects that involve secondary data analyses or development of statistical methodology using existing genome-wide data, relevant to human dental or craniofacial conditions or traits. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 04682 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Exploratory Innovations in Biomedical Computational Science and Technology (R21) Contact: Peter Lyster, Ph.D. Tel: 301-451-6446 Email: lysterp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-219.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invites applications for research and developments in computational science and technology that will support rapid progress in areas of scientific opportunity in biomedical research. As defined here, biomedical computing or biomedical information science and technology includes database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic collaboration, as well as computational and mathematical research including the development of structural, functional, integrative, and analytical models and simulations. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 74259 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) Contact: Linda Brady, Ph.D. Tel: 301-443-3563 Email: lbrady@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-023.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 89591 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (Phased Innovation Award [R21/R33]) Contact: Linda Brady, Ph.D. Tel: 301-443-3563 Email: lbrady@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-024.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies. This program will use the NIH Exploratory/Developmental Grant and Exploratory/Developmental Grant Phase II Phased Innovation Grant (R21/R33) award mechanisms. --------------------------------------------------------------- Program Number: 90921 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Drug Discovery for Nervous System Disorders (R21) Contact: Jamie Driscoll Tel: 301-443-5288 Email: jdrisco1@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-002.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invites applications from applicant organizations directed toward the discovery and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 91466 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: Neurobiology of Migraine (R21) Contact: Linda L. Porter, Ph.D. Tel: 301-496-9964 Email: porter@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-259.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations that intend to perform innovative research that will expand our current knowledge of neurobiological mechanisms underlying migraine headache, examine the role of neuromodulators, genetic and environmental influences in migraine susceptibility, and explore new targets for therapy development. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 02509 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R21) Contact: Wen G. Chen, Ph.D. Tel: 301496-9350 Email: chenw@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-194.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications from institutions/organizations that propose to (1) study biological, neurobiological, psychosocial, and clinical mechanisms and processes by which aging and/or age-related diseases affect the experience of pain, (2) examine biological, neurobiological, psychosocial, and clinical factors that impact pain experience and prevalence in older people, (3) evaluate existing pain assessment and/or management approaches in older adults, or (4) develop new assessment methods and/or management strategies for pain with particular attention to the needs of older adults. Studies involving animal models or human subjects are appropriate under this program announcement. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 02510 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R03) Contact: Wen G. Chen, Ph.D. Tel: 301496-9350 Email: chenw@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-195.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications from institutions/organizations that propose to (1) study biological, neurobiological, psychosocial, and clinical mechanisms and processes by which aging and/or age-related diseases affect the experience of pain, (2) examine biological, neurobiological, psychosocial, and clinical factors that impact pain experience and prevalence in older people, (3) evaluate existing pain assessment and/or management approaches in older adults, or (4) develop new assessment methods and/or management strategies for pain with particular attention to the needs of older adults. Studies involving animal models or human subjects are appropriate under this program announcement. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 46809 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Grants for Alzheimer's Disease Drug Discovery (R21) Contact: Suzana S. Petanceska, Ph.D. Tel: 301-496-9350 Email: petanceskas@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-151.html Deadline Note: This FOA will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications to advance the discovery of new, efficacious therapies for the treatment, delay of progression, or prevention of Alzheimer’s disease (AD), mild cognitive impairment (MCI) and age-related cognitive decline. This FOA encourages the early stages of drug discovery necessary to identify promising disease-modifying therapies as well as treatments aimed at ameliorating the cognitive and neuropsychiatric/behavioral symptoms characteristic of Alzheimer’s disease. Studies aimed at the discovery and testing of therapies directed at a variety of established as well as novel therapeutic targets are encouraged. The goal is not to duplicate or compete with pharmaceutical companies but to encourage the process of discovering new, innovative, and effective therapeutics for the prevention and treatment of the cognitive impairment and behavioral symptoms associated with Alzheimer's disease. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 16994 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Behavioral Regulation Mechanisms of Alcohol Dependence and Related Phenotypes (R21) Contact: Ivana Grakalic, Ph.D. Tel: 301-443-7600 Email: igrakalic@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-256.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications that propose to examine the mechanisms of behavioral regulation contributing to the behavioral characteristics of alcohol dependence. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 20845 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Neuroimmune Mechanisms Of Alcohol Related Disorders (R21) Contact: Changhai Cui, PhD Tel: 301-443-1678 Email: changhai.cui@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-065.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose study the neuroimmune mechanisms of alcohol related disorders. Studies supported by this FOA will provide fundamental insights of neuroimmune mechanisms underlying brain functional and behavioral changes induced by alcohol. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24140 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Drug Abuse Prevention Intervention Research (R21) Contact: Kevin P. Conway, Ph.D., Acting Branch Chief Tel: 301-443-6504 Email: kconway@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-312.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose to advance the science of drug abuse and drug-related HIV prevention through 1) the development of novel prevention approaches, 2) the testing of novel and adapted prevention intervention approaches 3) the elucidation of processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions, and 4) the development of new methodologies suitable for the design and analysis of prevention research studies. Programs of research are intended to provide pathways toward the discovery of population-level approaches for the prevention of drug abuse and dependence, drug-related problems (such as mental health, interpersonal violence, criminal involvement, and productivity loss), and drug-related disorders (e.g., comorbid drug and psychiatric disorders; infections such as HIV, hepatitis B, and hepatitis C). This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24141 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Drug Abuse Prevention Intervention Research (R03) Contact: Kevin P. Conway, Ph.D., Acting Branch Chief Tel: 301-443-6504 Email: kconway@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-313.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose to advance the science of drug abuse and drug-related HIV prevention through 1) the development of novel prevention approaches, 2) the testing of novel and adapted prevention intervention approaches 3) the elucidation of processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions, and 4) the development of new methodologies suitable for the design and analysis of prevention research studies. Programs of research are intended to provide pathways toward the discovery of population-level approaches for the prevention of drug abuse and dependence, drug-related problems (such as mental health, interpersonal violence, criminal involvement, and productivity loss), and drug-related disorders (e.g., comorbid drug and psychiatric disorders; infections such as HIV, hepatitis B, and hepatitis C). This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 87529 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R21) Contact: Redonna Chandler, Ph.D. Tel: 301-443-8768 Email: rchandle@nida.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-128.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2012. SYNOPSIS: The sponsors invite applications for health services and economic research to improve the quality of prevention, treatment, and recovery support services for drug, alcohol and tobacco abuse. Such research projects might emphasize any of the following subjects: (1) clinical quality improvement; (2) organization and delivery of services; (3) implementation research; (4) economic and cost studies; or (5) development or improvement of research methodology, analytic approaches, and measurement instrumentation used in the study of drug, alcohol, and tobacco prevention, treatment, and recovery services. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 87632 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) Contact: Cora Lee Wetherington, Ph.D. Tel: 301-435-1319 Email: cwetheri@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-11-048.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 87634 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03) Contact: Cora Lee Wetherington, Ph.D. Tel: 301-435-1319 Email: cwetheri@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-11-049.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 10017 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: Office of Research Infrastructure Programs/NIH/DHHS Title: Development of Animal Models and Related Biological Materials For Research (R21) Contact: Michael C. Chang, Ph.D. Tel: 301-435-0744 Email: changmic@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-138.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2010. SYNOPSIS: The sponsor solicits applications from institutions/ organizations that propose to develop, characterize or improve animal models for human disease or to improve diagnosis and control diseases of laboratory animals that may interfere with research. Models to be considered must be applicable to the research interests of two or more categorical NIH Institutes/Centers. Investigators considering applying are strongly encouraged to consult with NCRR program staff as early as possible to be advised whether this FOA is appropriate. Proposals to develop models that would not have broad applications, but would apply only to a specific disease or category of research, should be proposed to the appropriate categorical institute of the National Institutes of Health (NIH), e.g., models or model systems with primary focus on cancer or heart diseases should contact those categorical institutes at NIH to discuss alternative funding opportunities. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 28231 --------------------------------------------------------------- ***Deadlines: 6/18/2012 Sponsor: Golden Field Office/Department of Energy Title: Plug and Play Photovoltaics Contact: Kenneth L. Outlaw Tel: Email: PlugandPlayFOA@go.doe.gov Website:          http://www.grants.gov/search/search.do;jsessionid=52RlPT2RJLnTQ2JJJLn6gZ2v1LzfKfrZNJXL9J6KSQLXDBwYClrt!-889918338?oppId=164933&mode=VIEW Full Program:          https://eere-exchange.energy.gov/Default.aspx#bf5631a6-44d3-4d22-9034-9d0dc0bdf3d3 Deadline Note: Applicants are requested to submit a Letter of Intent by 5/16/2012, no later than 5:00PM Eastern Time. This letter should include the name of the applicant, the title of the project, the name of the Project Director/Principal Investigator(s), the amount of funds requested, and a one-page abstract. Letters of Intent and accompanying abstracts will be used by DOE to organize and expedite the merit review process. They should not contain any proprietary or sensitive business information. Failure to submit such letters will not negatively affect a responsive application submitted in a timely fashion. Full applications must be received by June 18, 2012. SYNOPSIS: The objective of this Department of Energy (DOE) Funding Opportunity Announcement (FOA) is to develop transformational solar technologies and systems utilizing a Plug and Play concept with a focus in the residential photovoltaic (PV) market. DOE is launching this FOA to challenge the broad Solar Research and Development (R&D) community to come up with radically new designs and frameworks for the next generation of solar panels and photon-to-electron conversion technologies. One scenario may be a university-led program [similar to the National Science Foundation’s (NSF) Engineering Research Centers (ERC)] with strong participation from industry, utilities, local authorities having jurisdiction and national laboratories. Projects funded under this FOA will take a fresh look at the relationships, as a whole, between the electricity consumers, utilities, and distributed PV generation. These projects will explore new technology pathways that reduce the so-called soft costs of the Balance of System (including permitting, inspection, and grid interconnection), ease of installation, and enhancement to performance, reliability, flexibility, and safety of the PV system. In addition, projects funded under this FOA will test and validate the feasibility of these technologies in the field. --------------------------------------------------------------- Program Number: 28808 --------------------------------------------------------------- ***Deadlines: 6/18/2012 Sponsor: Golden Field Office/Department of Energy Title: In-Water Wave Energy Conversion (WEC) Device Testing Support Contact: Shannon Dennison Tel: Email: shannon.dennison@go.doe.gov Website:          https://eere-exchange.energy.gov/#FoaId2658c370-aee4-45c9-a432-c51e4b1140af Full Program:          http://www.grants.gov/search/search.do;jsessionid=R8DfP68MD1ZfRgZxLQQC4VLCt4gBd41ZMsBKpHHTyPbpGJRkMPP2!1694693328?oppId=171433&mode=VIEW SYNOPSIS: The DOE is working closely with The Department of Navy (Navy) to support and promote wave energy technologies. This FOA will support the testing of one WEC device at the Navy’s existing 30m Wave Energy Test Site (WETS) located at Marine Corps Base Hawaii (MCBH), Kaneohe Bay, Hawaii. Only WEC buoy (point-absorber) device types are being considered for funding at this time. --------------------------------------------------------------- Program Number: 28683 --------------------------------------------------------------- ***Deadlines: 6/18/2012 Sponsor: National Energy Technology Laboratory/Department of Energy Title: Novel Sensing and Monitoring Technologies for Subsurface Detection of CO2 Contact: Maureen Davison Tel: 412-386-5163 Email: Maureen.Davison@netl.doe.gov Website:          http://www.grants.gov/search/search.do;jsessionid=8KvWPxsbfSsJh9Bz353208t32drzj31Lm891H1nMnXTf1lLBqTdV!477727685?oppId=170233&mode=VIEW Full Program:          https://www.fedconnect.net/FedConnect/?doc=DE-FOA-0000732&agency=DOE SYNOPSIS: The overall goal of the Department of Energy’s (DOE’s) programs have been to develop and advance technologies that will significantly improve the efficacy of the geologic carbon storage monitoring technologies, reduce the cost of implementation, and be ready for widespread commercial deployment between 2020 and 2030. This Funding Opportunity Announcement (FOA) complements a primary objective of the DOE’s Carbon Storage Program: to ensure 99% permanence through the monitoring, measurements, and accounting for CO2 injected in the geologic formations. This FOA requests applications that develop deep subsurface monitoring sensor technologies to ensure secure geologic storage of CO2 as described in the following program area of interest. It is envisioned that awards under this action will be structured as two to three year awards with decision points. Project continuation will be determined through continuation applications at the end of each budget period for all projects. --------------------------------------------------------------- Program Number: 28559 --------------------------------------------------------------- ***Deadlines: 6/18/2012 Sponsor: Nuclear Regulatory Commission Title: RFP -- Level 2 PRA Logic Model Development and Thermal-Hydraulic Modeling and Analysis Support for the Full-Scope Site Level 3 PRA Project Contact: Claudia G. Melgar Tel: 301-492-3487 Email: Claudia.Melgar@nrc.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=b718ab37d63c0782d4fb2cfbd08a6735&tab=core&_cview=0 SYNOPSIS: A -- LEVEL 2 PRA LOGIC MODEL DEVELOPMENT AND THERMAL-HYDRAULIC MODELING AND ANALYSIS SUPPORT FOR THE FULL-SCOPE SITE LEVEL 3 PRA PROJECT SOL NRC-HQ-2-R-04-0099 POC Claudia G. Melgar, Phone: 301-492-3487, Jennifer A. Defino, Phone: 301-492-3637 WEB: FBO.gov Permalink https://www.fbo.gov/spg/NRC/OA/DCPM/NRC-HQ-12-R-04-0099/listing.html E-MAIL: Claudia.Melgar@nrc.gov, Jennifer.DeFino@nrc.gov Claudia.Melgar@nrc.gov, Jennifer.DeFino@nrc.gov NAICS: 541690 A full-scope site Level 3 probabilistic risk assessment (PRA) for a nuclear power plant site can provide valuable insights into the relative importance of various risk contributors by assessing accidents involving the reactor core as well as other site radiological sources (i.e., spent fuel pools, dry storage casks, and multiple units). These insights can be used to further enhance regulatory decision making and to help focus limited agency resources on issues most directly related to theagency's mission to protect public health and safety. Although Level 3 PRAs have since been performed to some extent within both the United States and international nuclear industries, the U.S. Nuclear Regulatory Commission (NRC) has not sponsored development of a Level 3 PRA for a nuclear power plant site since NUREG-1150. In the more than two decades that have passed since the NUREG-1150 Level 3 PRAs were performed, numerous technical advances have been made that were not reflected in the NUREG-1150 PRA models. The staff has also identified additionalscope considerations not previously considered that could be addressed by performing a new full-scope site Level 3 PRA. A Level 2 PRA model provides 1) a structured and comprehensive evaluation of containment performance in response to accident sequences identified from the Level 1 analysis and 2) a quantitative characterization of radiological release to the environment that would result from accident sequences that involve leakage from the containment pressure boundary. Deterministic T-H modeling and analyses serve as the basis for many of the assumptions used in the Level 2 as well as the Level 1 PRA logic models. As such, the T-H models and analyses must adequately represent those systems and phenomena that are being modeled so that the PRA logic model represents realistic plant response to various accident scenarios. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=b718ab37d63c0782d4fb2cfbd08a6735&tab=core&_cview=0 Posted 05/04/12 (W-SN02739931). (0125) --------------------------------------------------------------- Program Number: 27807 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: Environmental Protection Agency Title: Measurements and Modeling for Quantifying Air Quality and Climatic Impacts of Residential Biomass or Coal Combustion for Cooking, Heating, and Lighting Contact: James Gentry Tel: 703-347-8093 Email: gentry.james@epa.gov Website:          http://www.grants.gov/search/search.do;jsessionid=1lpxPpbcLnz9CxR56JHWWzRxxN0Gf91YG22QNpRrQcK22GlvzzRX!545677704?oppId=156413&mode=VIEW Full Program:          http://www.epa.gov/ncer/rfa/2012/2012_star_cook_heat_light.html SYNOPSIS: The sponsor is seeking applications proposing research on quantifying, via field measurements and modeling, the improvements in climate and ambient and indoor air quality, and the subsequent impacts on health and welfare, resulting from ongoing, planned, or potential interventions in cooking, heating, or lighting practices. This research should focus on communities in the developing world and on Indian tribes and Alaska Native groups. --------------------------------------------------------------- Program Number: 27843 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: Environmental Protection Agency Title: Measurements and Modeling for Quantifying Air Quality and Climatic Impacts of Residential Biomass or Coal Combustion for Cooking, Heating, and Lighting (EPA-G2012-STAR-E1) Contact: James Gentry Tel: 703-347-8093 Email: gentry.james@epa.gov Website:          http://www.grants.gov/search/search.do;jsessionid=Zx3wPrHBzqQpMBYhSM62jvy32f9FGy4L54h6F1RpQ1Thg0smhSpH!1869518295?oppId=156213&mode=VIEW Full Program:          http://www.epa.gov/ncer/rfa/2012/2012_star_cook_heat_light.html SYNOPSIS: The sponsor is seeking applications proposing research on quantifying, via field measurements and modeling, the improvements in climate and ambient and indoor air quality, and the subsequent impacts on health and welfare, resulting from ongoing, planned, or potential interventions in cooking, heating, or lighting practices. This research should focus on communities in the developing world and on Indian tribes and Alaska Native groups. --------------------------------------------------------------- Program Number: 99701 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Small Grants for Behavioral Research in Cancer Control (R03) Contact: Gina Tesauro, MSW, Public Health Adviso Tel: 301-435-2836 Email: gina.tesauro@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-035.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 17, 2012. Letters of intent are not required for this FOA. The final deadlines for receipt of full applications are: February 17, 2012; June 19, 2012; October 18, 2012, by 5:00 PM local time of applicant organization. This program will expire on October 19, 2012. SYNOPSIS: National Cancer Institute (NCI) invites applications for research projects that can be carried out in a short period of time with limited resources in behavioral research in cancer prevention and control. This FOA is designed to enhance basic and applied behavioral sciences research in the context of cancer control, with a secondary goal of attracting new investigators to the field from a variety of biomedical, behavioral and public health disciplines. Proposed research projects would include pilot or feasibility studies, secondary analyses of existing data, and meta-analyses particularly in the areas of: (1) basic biobehavioral and psychological services, (2) behavioral genetics, (3) cancer survivorship and bereavement, (4) health behaviors, (5) health communication and informatics, (6) health disparities, (7) processes of cancer care including delivery and utilization, and (8) tobacco control. To be appropriate for this FOA, proposed research must be significantly applicable to cancer control research and address specific gaps in knowledge or methodologies. Although the specific study proposed may attempt only to obtain preliminary data and/or conduct pilot studies in support of a future, more detailed study, it is important that a long-term human cancer control hypothesis and supporting scientific justification be presented. Investigators new to the field of behavioral cancer control research, including early-stage and established investigators looking to refocus or apply their expertise to cancer control, are encouraged to apply for this small grants announcement. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 28161 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: RFA-HG-12-005--Specialized Centers of Excellence in ELSI Research (CEER) (P50) Contact: Ms. Joy T. Boyer Tel: 301-402-4997 Email: jb40m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-HG-12-005.html Deadline Note: The deadline for receipt of optional letters of intent is June 19, 2012. The deadline for receipt of full applications is .July 19, 2012. SYNOPSIS: National Human Genome Research Institute (NHGRI) invites applications for the support of Specialized Centers (P50) of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEERs). The CEER program is designed to develop and support trans-disciplinary research teams that have the expertise and flexibility to anticipate, conduct research on, and respond quickly to a range of ELSI issues related to the rapidly increasing availability and use of genomic approaches and information. CEERs are intended to provide an opportunity to cross disciplinary boundaries and create new research opportunities between and among investigators such as those in the basic genomic and social sciences, clinical and health policy research, ethics, law, the humanities, and various stakeholder communities. In addition, CEERs will play a role in ensuring that relevant ELSI research findings and deliberations are made available to policy makers as appropriate. Finally, CEERs will be responsible for contributing to training the next generation of ELSI researchers, with particular emphasis on training researchers from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds. This FOA will utilize the NIH P50 Specialized Center award mechanism. --------------------------------------------------------------- Program Number: 28162 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: RFA-HG-12-012--Exploratory Centers of Excellence in ELSI Research (CEER) (P20) Contact: Ms. Joy T. Boyer Tel: 301-402-4997 Email: jb40m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-HG-12-012.html Deadline Note: The deadline for receipt of optional letters of intent is June 19, 2012. The deadline for receipt of full applications is .July 19, 2012. SYNOPSIS: National Human Genome Research Institute (NHGRI) invites applications for the support of Exploratory Centers (P20) of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEERs). Exploratory Centers will support expanding or modifying existing resources at an institution for the purpose of developing a Specialized Center (P50) CEER application. The CEER program is designed to develop and support trans-disciplinary research teams that have the expertise and flexibility to anticipate, conduct research on, and respond quickly to a range of ELSI issues related to the rapidly increasing availability and use of genomic approaches and information. CEERs are intended to provide an opportunity to cross disciplinary boundaries and create new research opportunities between and among investigators such as those in the basic genomic and social sciences, clinical and health policy research, ethics, law, the humanities, and various stakeholder communities. In addition, CEERs will play a role in ensuring that relevant ELSI research findings and deliberations are made available to policy makers as appropriate. Finally, CEERs will be responsible for contributing to training the next generation of ELSI researchers, with particular emphasis on training researchers from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds. This FOA will utilize the NIH P20 Exploratory Grants award mechanism. --------------------------------------------------------------- Program Number: 27969 --------------------------------------------------------------- ***Deadlines: 6/21/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: RFA-CA-12-006--Cancer Target Discovery and Development (CTDD) Network (U01) Contact: Daniela S. Gerhard, Ph.D., Director Tel: 301-451-8027 Email: gerhardd@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-006.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 21, 2012. The deadline for receipt of optional letters of intent is May 21, 2012. The deadline for receipt of full applications is June 21, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Cancer Institute (NCI) invites applications for innovative research on high throughput approaches to the discovery and characterization of new cancer targets and their modulators. Projects resulting from this FOA are expected to bridge the gap between the enormous volumes of data generated by the comprehensive molecular characterizations of many cancer subtypes and the ability to use these data for the development of human cancer therapeutics and associated response markers. Applicants must propose research projects focused on high-throughput identification and/or characterization of potential targets for cancer therapy, and/or the identification of small molecules that modulate validated cancer targets. Proposed projects are expected to combine in-depth mining of large-scale genomic data, systems biology analyses and/or experimental approaches to provide initial characterization of functional significance. This characterization may involve the studies of modulation/perturbation of the potential targets (or target combinations) using, e.g., small molecules and/or oligonucleotides. Development and/or improvement of technologies serving the main goals of the project may also be proposed. In addition to conducting individual research projects, the CTDD awardees will also be expected to contribute to trans-Network activities, including participation in joint pilot research projects. Successful applicants will join the existing Network. This program will use the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 22255 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: National Cooperative Drug Discovery/ Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U19) Contact: Linda Brady, Ph.D., Director Tel: 301-443-3563 Email: lbrady@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-207.html Deadline Note: The deadlines for receipt of optional letters of intent are: September 26, 2011; January 24, 2012; May 22, 2012; September 24, 2012; January 22, 2013. The corresponding deadlines for receipt of full applications are: October 24, 2011; February 24, 2012; June 22, 2012; October 22, 2012; February 22, 2013 . This program will expire on February 23, 2013. SYNOPSIS: The sponsors provide support for multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness, drug or alcohol addiction. The objectives of this program are to: accelerate innovative drug discovery; develop pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction; develop and validate models for evaluating novel therapeutics for mental disorders; and support early phase human clinical testing to rapidly assess the safety and efficacy of promising drug candidates and new indications for IND-ready drugs for the treatment of mental disorders or alcohol addiction. The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite applications to advance the discovery, preclinical development, and proof of concept testing of new, rationally based candidate medications to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Partnerships between academia and industry are strongly encouraged. This FOA will utilize the NIH U19 Research Program – Cooperative Agreements award mechanisms. --------------------------------------------------------------- Program Number: 77083 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: National Cooperative Drug Discovery/ Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (UM1) Contact: Linda Brady, Ph.D., Director Tel: 301-443-3563 Email: lbrady@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-206.html Deadline Note: The deadlines for receipt of optional letters of intent are: September 26, 2011; January 24, 2012; May 22, 2012; September 24, 2012; January 22, 2013. The corresponding deadlines for receipt of full applications are: October 24, 2011; February 24, 2012; June 22, 2012; October 22, 2012; February 22, 2013 . This program will expire on February 23, 2013. SYNOPSIS: The sponsors provide support for multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness, drug or alcohol addiction. The objectives of this program are to: accelerate innovative drug discovery; develop pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction; develop and validate models for evaluating novel therapeutics for mental disorders; and support early phase human clinical testing to rapidly assess the safety and efficacy of promising drug candidates and new indications for IND-ready drugs for the treatment of mental disorders or alcohol addiction. The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite applications to advance the discovery, preclinical development, and proof of concept testing of new, rationally based candidate medications to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Partnerships between academia and industry are strongly encouraged. This FOA will utilize the NIH UM1 Multi-Component Research Project Cooperative Agreements award mechanisms. --------------------------------------------------------------- Program Number: 91083 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: NIDCD Research Grants for Translating Basic Research into Clinical Tools for Human Health (R01) Contact: Amy M. Donahue, Ph.D. Tel: 301-402-3458 Email: donahuea@nidcd.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-003.html Deadline Note: The deadlines for receipt of optional letters of intent are: May 22, 2012, January 22, 2013 and September 22, 2013. The deadlines for receipt of full applications are: June 22, 2012, February 22, 2013 and October 22, 2013. This program will expire on October 23, 2013. SYNOPSIS: The sponsor offers support for applications which translate basic research findings into clinical tools for better human health in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech and language. The intent of this Funding Opportunity Announcement (FOA) is to provide a new avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects. The scope of this FOA includes a range of activities to encourage translation of basic research findings which will impact the diagnosis, treatment and prevention of communication disorders. Multi-institutional, multi-disciplinary, and academic-industrial collaborations studies are encouraged. This FOA is not intended for outcome studies, the extension of ongoing clinical research studies, the optimization of current clinical protocols, or pre-translational studies. Connection to the clinical condition must be clearly established and the outcomes of the grant must have practical clinical impact. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 28287 --------------------------------------------------------------- ***Deadlines: 6/26/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: RFA-HG-12-008--Clinical Sequencing Exploratory Research Coordinating Center (U01) Contact: Lucia A. Hindorff, Ph.D., M.P.H. Tel: 301-496-7531 Email: hindorffl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-HG-12-008.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after June 26, 2012. The deadline for receipt of optional letters of intent is June 26, 2012. The deadline for receipt of full applications is July 26, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Human Genome Research Institute (NHGRI) invites applications for centralized support and coordination for the studies and investigators funded under the the Clinical Sequencing Exploratory Research (CSER) program (RFA-HG-10-017 and RFA-HG-12-009), who will explore, within an active clinical setting, the application of genomic sequence data to the care of patients, as well as the studies and investigators in the Return of Results (RoR) Consortium, which encompasses elements of the CSER program and studies supported under the Ethical, Legal, and Social Implications program RFA-HG-11-003 and RFA-HG-11-004. This program will use the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 05829 --------------------------------------------------------------- ***Deadlines: 6/27/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Grand Opportunity in Medications Development for Substance-Related Disorders (U01) Contact: Ivan D. Montoya, M.D., M.P.H. Tel: 301-443-8639 Email: imontoya@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-109.html Deadline Note: The deadlines for receipt of optional letters of intent are: April 26, 2011 (passed), July 26, 2011, February 27, 2012, June 27, 2012, February 27, 2013, June 26, 2013. The deadlines for receipt of full applications are: May 26, 2011, August 26, 2011, March 27, 2012, July 27, 2012, March 27, 2013, July 26, 2013. This FOA will expire on August 15, 2013. SYNOPSIS: The sponsor invites applications to support a diverse array of preclinical and/or clinical research projects. The goal is to fund medication studies that will have high impact and quickly yield the necessary results to advance medications closer to FDA approval. It is expected that these U01s will be short-term (funded for up to 3 years) and large (up to $5 million per year) cooperative agreements with close monitoring and significant scientific involvement of NIDA staff. This funding mechanism will enable critical medications development studies that would not be feasible using the traditional R01 mechanism. This FOA will utilize the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 28724 --------------------------------------------------------------- ***Deadlines: 6/28/2012 Sponsor: National Energy Technology Laboratory/Department of Energy Title: Unconventional Gas and Oil Technologies Contact: Anne M. Cary Tel: 412-386-5885 Email: anne.cary@netl.doe.gov Website:          http://www.grants.gov/search/search.do;jsessionid=Nzt8PzGDgCJPJ4jkyF6GJt2JjMdfD5lPVqTrc1LpN3wb5G82t0sS!-253887325?oppId=170615&mode=VIEW Full Program:          https://www.fedconnect.net/fedconnect/?doc=DE-FOA-0000724&agency=DOE SYNOPSIS: The intent of this Department of Energy (DOE), National Energy Technology Laboratory (NETL) funding opportunity announcement (FOA) is to select and award projects in FY12 that focus on improving recovery from liquid-rich shale reservoirs and to advance the development of “next generation” carbon dioxide (CO2) enhanced oil recovery (EOR) technologies. This announcement is a critical component of the DOE portfolio to advance the sustainable development of domestic gas and oil resources and it will support ongoing programmatic efforts to (1) improve our understanding of the occurrence, producability, and environmental impacts of unconventional shale resources and (2) expand the use of a greenhouse gas to increase the recovery of domestic oil resources. --------------------------------------------------------------- Program Number: 01356 --------------------------------------------------------------- ***Deadlines: 6/29/2012 Sponsor: National Aeronautics & Space Administration Title: ROSES 2012: Physical Oceanography Contact: Dr. Eric Lindstrom Tel: 202-358-4540 Email: Eric.J.Lindstrom@nasa.gov Website:          http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={40AF4187-005B-B1D3-B070-A9BB3F5E58A3}&path=open Full Program:          http://www.grants.gov/search/search.do;jsessionid=rh8QPJGD5lJ2JcGtLcJYlGpqT4qTWQGMd8Vn6gD4SknjvXW2HxDS!-889918338?oppId=148636&mode=VIEW Deadline Note: Optional letters of intent are requested to be submitted by April 30, 2012. Full applications are due June 29, 2012. SYNOPSIS: NASA’s Physical Oceanography program supports basic research and analysis activities that enable development of NASA’s current and future physical oceanography satellite missions and the scientific interpretation of data from them. The primary centers of support for the Physical Oceanography program are at the NASA Goddard Space Flight Center Laboratory for Hydrospheric Processes, the NASA Jet Propulsion Laboratory Earth Science Directorate, and the external (non-NASA) scientific community. This announcement serves as the vehicle for participation in the Physical Oceanography program for all institutions.